Glucose Transporter Type 2 - Does It Pave the Way to Sporadic Alzheimer's Disease? (CROSBI ID 550869)
Prilog sa skupa u zborniku | sažetak izlaganja sa skupa | međunarodna recenzija
Podaci o odgovornosti
Salkovic-Petrisic, Melita ; Grünblatt, Edna ; Osmanovic, Jelena ; Hoyer, Siegfried ; Riederer, Peter
engleski
Glucose Transporter Type 2 - Does It Pave the Way to Sporadic Alzheimer's Disease?
Background: Sporadic type of Alzheimer’ s disease (sAD) is associated with brain insulin receptor (IR) signalling abnormalities. The sequence of these events in relation to the beta amyloid (Aβ ) pathology can be traced only in sAD animal model, rats treated intracerebroventricularly with streptozotocin (STZ-icv). STZ enters the cell through glucose transporter type 2 (GLUT2) and selectively damages insulin producing/secreting cells and IR, as well as GLUT2. The time course of brain insulin system dysfunction following damage induced by icv application of GLUT2- and IR-toxic drug was investigated in this sAD model. Methods: Male Wistar rats (3-4 month old, 6-8 per group) were treated bilaterally icv with STZ (1-3 mg/kg) and followed after 1, 3 and 6 months for the memory (Morris Water Maze Swimming Test), hippocampal neurochemistry (RT-PCR for insulin-1 /Ins-1/, IR and insulin degrading enzyme /IDE/, immunoblotting for IR, protein kinase B /Akt/PKB/, glycogen synthase kinase 3 /GSK-3/, IDE, tau protein, and Elisa assay for tyrosine kinase /TK/), and histology (immunohistochemistry and Congo red staining for Aβ ). Data were analysed by Kruskal Wallis median and Mann Whitney U test. Results: One month following the STZ-icv treatment IR mRNA and protein were decreased (p<0.05). Three months following the STZ-icv treatment Ins-1 and IR mRNA were decreased (p<0.05) and IR-TK activity increased (p<0.05). This was followed by alterations (p<0.05) of downstream IR signaling elements, decreased expression of Akt/PKB and p-GSK-3/GSK-3 ratio, increased expression of hyperphosphorylated tau protein, and decreased expression of IDE mRNA and protein. Aβ -like congophilic capillary aggregates (cerebral amyloid angiopathy) and Aβ 1-42 intraneuronal aggregates were found after 3 months. Decreased expression of Ins-1, IR and IDE mRNA, IR and IDE protein were found 6 months after STZicv treatment when Aβ 1-42 primitive plaques were found in hippocampal/cortical regions. Cognitive deficits were found at each time point. Conclusions: STZ-icv induced damage of brain GLUT2 and IR leads to insulin resistant brain state eventually triggering Aβ pathology in animal sAD model. Supported by DAAD and MZOS.
sporadic Alzheimer disease; insulin receptor; brain; GLUT-2; amyloid beta
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
2008.
objavljeno
Podaci o matičnoj publikaciji
Book of Abstracts
Podaci o skupu
Ehrlich II: Magic bullet Conference on the occasion of the 100th Anniversary of the Nobel Prize awarded to Paul Ehrlich
pozvano predavanje
03.10.2008-05.10.2008
Nürnberg, Njemačka